TransCode Therapeutics Reports 2022 Results; Provides Busine

BOSTON, March 31, 2023 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business... | March 31, 2023

Related Keywords

Texas , United States , Boston , Massachusetts , Zdravka Medarova , Michael Dudley , Alan Freidman , University Of Texas Md Anderson Cancer Center , Exchange Commission , Nasdaq , Transcode Therapeutics Inc , Transcode Co , Code Therapeutics , Chief Technology Officer , Orphan Drug Designation , Frank Slack , Private Securities Litigation Reform Act , Investigational New Drug , Nasdaq Capital Market , Annual Report , Transcode Therapeutics , Nc Stock Exchange , News , Information , Press Release , Arch , 023 , Transcode , The , Na , Ncology , Company , Ommitted , O , Defeating , Dancer , Sing , Oday , Eported , Financial , Results , Or , 022 , End , Ecent Rnaz Us89357l1052 ,